NCT07112170View on ClinicalTrials.gov

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

NARecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

July 24, 2027

Study Completion Date

July 24, 2028

Conditions
Metastatic MelanomaOligoProgressive Metastatic Disease
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT)

SBRT will be delivered as per institutional standard.

Trial Locations (1)

Unknown

RECRUITING

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT07112170 - Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter